CN106913577A - A kind of new Diammonium Glycyrrhizinate ammonium composition medicine - Google Patents
A kind of new Diammonium Glycyrrhizinate ammonium composition medicine Download PDFInfo
- Publication number
- CN106913577A CN106913577A CN201510991084.4A CN201510991084A CN106913577A CN 106913577 A CN106913577 A CN 106913577A CN 201510991084 A CN201510991084 A CN 201510991084A CN 106913577 A CN106913577 A CN 106913577A
- Authority
- CN
- China
- Prior art keywords
- diammonium glycyrrhizinate
- ammonium
- new
- composition
- gross mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of new Diammonium Glycyrrhizinate ammonium composition medicine, including the ammonium of alpha-liquorice acid two, β-diammonium glycyrrhizinate and ethacrynic acid, the ammonium of the alpha-liquorice acid two accounts for the 45-70% of composition gross mass, β-the diammonium glycyrrhizinate accounts for the 5-8% of composition gross mass, and the ethacrynic acid accounts for the 10-20% of composition gross mass.New Diammonium Glycyrrhizinate ammonium composition medicine of the invention can be used in the hepatopathy disease that treatment is caused due to virus, and therapeutic effect is good, has no side effect.
Description
Technical field
The present invention relates to Diammonium Glycyrrhizinate ammonium field, a kind of new Diammonium Glycyrrhizinate is specifically related to
Ammonium composition medicine.
Background technology
Diammonium Glycyrrhizinate ammonium is the third generation extract of glycyrrhiza uralensis fisch active ingredient, with certain
The effect of anti-inflammatory, protection liver plasma membrane and improvement liver function.But single use Diammonium Glycyrrhizinate
Its therapeutic effect of ammonium is limited.
The content of the invention
(1) technical problem to be solved
In view of the shortcomings of the prior art, the present invention provides a kind of for treating liver diseases
New Diammonium Glycyrrhizinate ammonium composition medicine.
(2) technical scheme
To reach above-mentioned purpose, the invention provides a kind of new Diammonium Glycyrrhizinate ammonium composition
Medicine, including the ammonium of alpha-liquorice acid two, β-diammonium glycyrrhizinate and ethacrynic acid, the alpha-liquorice acid
Two ammoniums account for the 45-70% of composition gross mass, and the β-diammonium glycyrrhizinate accounts for composition gross mass
5-8%, the ethacrynic acid accounts for the 10-20% of composition gross mass.
Further, for treating due to the hepatopathy disease that virus causes.
Further, also including monopotassium glycyrrhizunate.
(3) beneficial effect
The new Diammonium Glycyrrhizinate ammonium composition medicine of the present invention can be used in treatment because virus is drawn
The hepatopathy disease for rising, therapeutic effect is good, has no side effect.
Specific embodiment
With reference to embodiment, specific embodiment of the invention is described in further detail.
Following examples are used to illustrate the present invention, but are not limited to the scope of the present invention.
A kind of new Diammonium Glycyrrhizinate ammonium composition medicine of the invention, including alpha-liquorice acid two
Ammonium, β-diammonium glycyrrhizinate and ethacrynic acid, the ammonium of the alpha-liquorice acid two account for composition gross mass
45-70%, the β-diammonium glycyrrhizinate accounts for the 5-8% of composition gross mass, and the ethacrynic acid is accounted for
The 10-20% of composition gross mass.
In the present embodiment, for treating due to the hepatopathy disease that virus causes.
In the present embodiment, also including monopotassium glycyrrhizunate.
Beneficial effects of the present invention：Can be used in the hepatopathy disease that treatment is caused due to virus,
Therapeutic effect is good, has no side effect.
The above is only the preferred embodiment of the present invention, it is noted that led for this technology
For the those of ordinary skill in domain, on the premise of the technology of the present invention principle is not departed from, can be with
Some improvements and modifications are made, these improvements and modifications also should be regarded as protection scope of the present invention.
Claims (3)
1. a kind of new Diammonium Glycyrrhizinate ammonium composition medicine, it is characterised in that including α-
Diammonium glycyrrhizinate, β-diammonium glycyrrhizinate and ethacrynic acid, the ammonium of the alpha-liquorice acid two account for composition
The 45-70% of gross mass, the β-diammonium glycyrrhizinate accounts for the 5-8% of composition gross mass, described
Ethacrynic acid accounts for the 10-20% of composition gross mass.
2. new Diammonium Glycyrrhizinate ammonium composition medicine as claimed in claim 1, its feature
It is, for treating due to the hepatopathy disease that virus causes.
3. new Diammonium Glycyrrhizinate ammonium composition medicine as claimed in claim 1, its feature
It is, also including monopotassium glycyrrhizunate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510991084.4A CN106913577A (en) | 2015-12-25 | 2015-12-25 | A kind of new Diammonium Glycyrrhizinate ammonium composition medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510991084.4A CN106913577A (en) | 2015-12-25 | 2015-12-25 | A kind of new Diammonium Glycyrrhizinate ammonium composition medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106913577A true CN106913577A (en) | 2017-07-04 |
Family
ID=59459809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510991084.4A Pending CN106913577A (en) | 2015-12-25 | 2015-12-25 | A kind of new Diammonium Glycyrrhizinate ammonium composition medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106913577A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109620921A (en) * | 2019-01-25 | 2019-04-16 | 陶奇 | A kind of pharmaceutical preparation of the compound containing diammonium glycyrrhizinate |
-
2015
- 2015-12-25 CN CN201510991084.4A patent/CN106913577A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109620921A (en) * | 2019-01-25 | 2019-04-16 | 陶奇 | A kind of pharmaceutical preparation of the compound containing diammonium glycyrrhizinate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201290556A1 (en) | ORAL MEDICAL FORM, INCLUDING ENTEKAVIR | |
| CN104547893A (en) | Medicament for promoting blood circulation and diminishing swelling | |
| CN106913577A (en) | A kind of new Diammonium Glycyrrhizinate ammonium composition medicine | |
| CN106913578A (en) | A kind of Diammonium Glycyrrhizinate ammonium composition medicine | |
| MX2022004449A (en) | Dosages and uses of ornithine phenylacetate for treating hyperammonemia. | |
| CN103637968A (en) | Traditional Chinese medicine acne treatment mask | |
| CN106728359A (en) | Control the Chinese medicine preparation of delayed menstrual cycle | |
| CN104127610A (en) | Medicine for expelling rheumatism | |
| CN105687094A (en) | Traditional Chinese medicinal shampoo | |
| CN104399032A (en) | Traditional Chinese medicine composition for treating acute nephritis | |
| CN103768155A (en) | Traditional Chinese medicine decoction for preventing influenza | |
| CN106474477A (en) | A kind of detumescence spray | |
| CN107412597A (en) | A kind of Chinese medicine blood-sugar reducing tea for curing diabetes | |
| CN101904934A (en) | Drug for treating sciatica | |
| CN106138559A (en) | A kind of combination of Chinese medicine treating chronic eczema | |
| CN104257921A (en) | Drug for removing freckles | |
| CN110522856A (en) | Pharmaceutical composition with analgesic efficacy | |
| CN103656368A (en) | Medicinal liquor for treating psoriasis | |
| CN106581427A (en) | Traditional Chinese medicine preparation for treating beriberi | |
| CN103638227A (en) | Aromatic resuscitation medicine | |
| CN103768154A (en) | Traditional Chinese medicine decoction for preventing influenza | |
| CN103656283A (en) | Traditional Chinese medicine liver-protecting tea | |
| CN106692441A (en) | Pure traditional Chinese medicinal oral liquid for treating sclerosis | |
| CN104997875A (en) | Traditional Chinese medicinal composition for treating trigeminal neuralgia | |
| CN102451402A (en) | Antitumor medicinal liquor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170704 |